Research Articles

Original Research

Post-market, Prospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium Used as a Patch in Vascular Repair and Reconstruction Surgery: PHOTO-V

12/14/2022

Larry Kraiss , MD;

Nicholas Osborne , MD;

Todd Russell , MD, FACS;

Wei Zhou , MD;

Nicholas J. Morrissey , MD;

B. Timothy Baxter , MD;

Michael Belkin , MD;

William T. Bohannon , MD, FACS;

Jose Borromeo , MD, FACS;

Nitin Garg , MBBS, MPH;

This article reports the results from the first clinical study of a BPP processed through photo-oxidation, without the use of glutaraldehyde, in procedures for CAS, as well as PAD.

This article reports the results...

12/14/2022

Vascular Disease Management

OBL Corner

The Value of Outpatient Based Labs for Endovascular Therapy of Peripheral Artery Disease: The Cardiovascular Institute of the South Experience

11/16/2022

Sarah Melvin , MSPH;

Pradeep K. Nair , MD, FACC, FSCAI;

A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.

A review of the safety,...

11/16/2022

Vascular Disease Management

Original Research

Role of Endovascular Interventions in the Management of COVID-19 Patients Presenting With Massive Hemorrhage: A Single-Center Experience

08/23/2022

Aparna Irodi , MBBS, MD, DNB, FRCR;

Leena Robinson Vimala , DMRD, MD, FSCMR;

Regi Kurien , MBBS, MS;

T. Balamugesh , MBBS, MD, DM, FRCP, FRCPS, FCCP;

Richa Gupta , MBBS, MD;

Santhosh Babu Bharathy , MD, MBBS;

Birla Roy Gnanamuthu , MBBS, MS;

Vinu Moses , MD, DNB, MBBS;

Shyamkumar Nidugala Keshava , MBBS, DMRD, DNB, FRCR, FRANZCR;

Kumar Muthukumar , MBBS, DMRD, FRCR, DNB, FNVIR;

This study included COVID-19-positive patients who presented with massive hemorrhage who were referred to interventional radiology.

This study included...

08/23/2022

Vascular Disease Management

Original Research

The Value of Clinical Risk Factors and Inflammatory Biomarkers in Isolated Coronary Artery Ectasia: A Cross-Sectional Study From a Tertiary Center

07/19/2022

Betul Balaban Kocas , MD;

Gokhan Cetinkal , MD;

Suleyman Sezai Yildiz , MD;

Kadriye Kilickesmez , MD;

This study evaluated the association of atherosclerotic risk factors and inflammatory biomarkers with isolated coronary artery ectasia.

This study evaluated the...

07/19/2022

Vascular Disease Management

Original Research

Edetate Disodium Infusions May Benefit Patients With Diabetes and Critical Limb-Threatening Ischemia

05/16/2022

Francisco Ujueta , MD, MS;

Carlos Vozzi ;

Ivan A. Arenas , MD, PhD;

Gervasio A. Lamas , MD;

Outcomes of CLTI patients with diabetes who underwent edetate disodium-based infusions.

Outcomes of CLTI patients with...

05/16/2022

Vascular Disease Management

Original Research

Assessment of Monocyte Count to HDL Cholesterol Ratio in Patients With Ascending Aortic Dilatation

04/21/2022

Gonul Aciksari , MD;

Betul Balaban Kocas , MD;

Gokhan Cetinkal , MD;

The authors investigate the relationship between monocyte count to HDL-C ratio and AAD.

The authors investigate the...

04/21/2022

Vascular Disease Management

Original Research

Comparative Analysis of Vascular Closure Devices to Traditional Manual Compression in OBLs

03/22/2022

Michael Patel , MD;

Warren Swee , MD, MPH;

Timothy E. Yates , MD, RPVI;

Jennifer Gimeno , MS;

Robert E. Beasley , MD, FSCAI, FSIR;

Anne Beasley ;

Jesse Martin , DO;

Daniel Braga , MD;

Vascular closure devices vs manual compression in OBLs.

Vascular closure devices vs...

03/22/2022

Vascular Disease Management

Original Research

A Hybrid Approach to Acute Limb Ischemia Utilizing Indigo Aspiration Thrombectomy in Conjunction With Catheter-Directed Thrombolysis

02/16/2022

Emily Rey , DO;

Roople Risam , MD;

Sahejpreet Kaur , MD;

Sang Lee , MD;

Ganesh Arun , DO;

Kristian Hochberg , MD;

Improving limb salvage outcomes.

02/16/2022

Vascular Disease Management

Original Research

Comparison of Invasive and Medical Treatment in Patients With Isolated Non-Ostial Side-Branch Stable Coronary Artery Disease

02/16/2022

Betul Balaban Kocas , MD;

Sukru Arslan , MD;

Omer Dogan , MD;

Tugay Yumuk , MD;

Onur Kilicarslan , MD;

Servet Batit , MD;

Okay Abaci , MD;

Dogan Sait Mesut , MD;

Cuneyt Kocas , MD;

Reviewing medical and invasive treatment strategies.

Reviewing medical and invasive...

02/16/2022

Vascular Disease Management

Fig 1. Renovisceral debranching procedure

Original Research

Blood Flow Analysis After a Renovisceral Debranching Procedure by Four-dimensional Flow Magnetic Resonance Imaging

01/19/2022

Takashi Shuto , MD, PhD;

Tomoyuki Wada , MD, PhD;

Takayuki Kawashima , MD;

Norio Hongo , MD, PhD;

Kazuki Mori , MD;

Shinji Miyamoto , MD, PhD;

Analyzing blood flow.

01/19/2022

Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared

11/20/2024

Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...

Hechingen, November 20th, 2024....

11/20/2024

Vascular Disease Management

First Aid guidelines

AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies

11/14/2024

These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.

These are the first major...

11/14/2024

Cath Lab Digest

Late-Breaking Trials

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/06/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...

The VIVA Foundation, a...

11/06/2024

Vascular Disease Management

Late-Breaking Trials

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/05/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/05/2024

Vascular Disease Management

Late-Breaking Trials

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Late-Breaking Trials

First Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Image-Guided Therapy

Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease

11/04/2024

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...

With a unique world-first...

11/04/2024

Vascular Disease Management

Pulmonary Embolism

Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism

11/04/2024

QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...

QUADRA-PE study will evaluate...

11/04/2024

Vascular Disease Management

Peripheral Arterial Disease

FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

11/04/2024

MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...

MOUNTAIN VIEW, Calif. – November...

11/04/2024

Vascular Disease Management

Patient Awareness

Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases

10/31/2024

New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...

New survey reveals nearly one in...

10/31/2024

Vascular Disease Management

Research Articles

Stay in the Know

News

Specialties

Events

Year Round Education

HMP Global Products